HighTower Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.8M Buy
78,110
+13,929
+22% +$3.77M 0.02% 604
2025
Q4
$16.1M Buy
64,181
+250
+0.4% +$66.4K 0.02% 681
2025
Q3
$18.4M Sell
63,931
-199
-0.3% -$53.3K 0.02% 624
2025
Q2
$16.8M Buy
64,130
+49,735
+346% +$12.1M 0.02% 606
2025
Q1
$3.35M Sell
14,395
-542
-4% -$132K ﹤0.01% 1241
2024
Q4
$3.43M Sell
14,937
-11,039
-42% -$2.53M ﹤0.01% 1223
2024
Q3
$5.79M Sell
25,976
-2,089
-7% -$459K 0.01% 973
2024
Q2
$5.71M Buy
28,065
+69
+0.2% +$14K 0.01% 956
2024
Q1
$6.11M Sell
27,996
-1,282
-4% -$282K 0.01% 886
2023
Q4
$6.66M Buy
29,278
+1,480
+5% +$311K 0.01% 851
2023
Q3
$5.58M Sell
27,798
-1,210
-4% -$255K 0.01% 881
2023
Q2
$6M Buy
29,008
+1,524
+6% +$296K 0.01% 826
2023
Q1
$5.42M Sell
27,484
-246
-0.9% -$50.6K 0.01% 820
2022
Q4
$5.61M Sell
27,730
-1,092
-4% -$213K 0.01% 805
2022
Q3
$5.06M Buy
28,822
+859
+3% +$176K 0.01% 798
2022
Q2
$5.63M Sell
27,963
-22,315
-44% -$4.76M 0.01% 765
2022
Q1
$11.4M Buy
50,278
+2,760
+6% +$649K 0.03% 568
2021
Q4
$12.8M Buy
47,518
+14,833
+45% +$3.67M 0.03% 514
2021
Q3
$7.9M Buy
32,685
+1,762
+6% +$444K 0.02% 645
2021
Q2
$7.36M Buy
30,923
+8,260
+36% +$1.88M 0.02% 643
2021
Q1
$4.98M Buy
22,663
+1,198
+6% +$240K 0.02% 736
2020
Q4
$3.73M Buy
21,465
+1,776
+9% +$307K 0.02% 680
2020
Q3
$3.2M Sell
19,689
-149
-0.8% -$23.6K 0.02% 710
2020
Q2
$2.83M Buy
19,838
+10,316
+108% +$1.43M 0.02% 688
2020
Q1
$1.04M Buy
9,522
+474
+5% +$68.3K 0.01% 987
2019
Q4
$1.31M Sell
9,048
-375
-4% -$54.1K 0.01% 1008
2019
Q3
$1.36M Buy
9,423
+688
+8% +$100K 0.01% 1032
2019
Q2
$1.3M Buy
8,735
+885
+11% +$123K 0.01% 1072
2019
Q1
$1.04M Sell
7,850
-450
-5% -$55.4K 0.01% 1120
2018
Q4
$904K Sell
8,300
-26,637
-76% -$3.57M 0.01% 1085
2018
Q3
$5.19M Buy
34,937
+1,736
+5% +$264K 0.04% 497
2018
Q2
$5.1M Buy
33,201
+851
+3% +$128K 0.04% 490
2018
Q1
$4.48M Buy
32,350
+3,088
+11% +$454K 0.04% 498
2017
Q4
$4.01M Buy
29,262
+6,544
+29% +$865K 0.03% 565
2017
Q3
$2.96M Buy
22,718
+2,388
+12% +$319K 0.03% 668
2017
Q2
$2.69M Buy
20,330
+5,425
+36% +$664K 0.02% 687
2017
Q1
$1.84M Buy
14,905
+8,054
+118% +$954K 0.02% 789
2016
Q4
$756K Buy
6,851
+451
+7% +$50.1K 0.01% 1094
2016
Q3
$756K Sell
6,400
-995
-13% -$117K 0.01% 1038
2016
Q2
$828K Sell
7,395
-12,338
-63% -$1.33M 0.01% 964
2016
Q1
$1.98M Sell
19,733
-3,058
-13% -$293K 0.01% 728
2015
Q4
$2.42M Sell
22,791
-30,818
-57% -$3.18M 0.03% 562
2015
Q3
$4.93M Buy
53,609
+8,979
+20% +$929K 0.07% 321
2015
Q2
$4.64M Buy
44,630
+5,921
+15% +$616K 0.07% 290
2015
Q1
$4.2M Buy
38,709
+257
+0.7% +$26.4K 0.06% 347
2014
Q4
$3.56M Buy
38,452
+288
+0.8% +$25.4K 0.05% 380
2014
Q3
$3.34M Buy
38,164
+1,273
+3% +$115K 0.06% 365
2014
Q2
$3.25M Buy
36,891
+3,518
+11% +$305K 0.06% 382
2014
Q1
$2.82M Buy
33,373
+7,117
+27% +$568K 0.05% 404
2013
Q4
$2.06M Buy
26,256
+378
+1% +$32.2K 0.04% 449
2013
Q3
$2.2M Buy
25,878
+101
+0.4% +$8.51K 0.06% 391
2013
Q2
$2.22M Buy
+25,777
New +$2.14M 0.06% 364

Other funds holding LH

HighTower Advisors's LH Position: Q1 2026 in Review

HighTower Advisors increased its Labcorp (LH) stake by 22% in Q1 2026, buying an estimated $3.77M and bringing the position to 78,110 shares worth $20.8M. The position accounts for 0.02% of the portfolio, ranked #604.

HighTower Advisors first reported a position in LH in Q2 2013 and has held it in 52 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • HighTower Advisors held 78,110 shares of Labcorp worth $20.8M as of Q1 2026.
  • HighTower Advisors bought 13,929 Labcorp shares in Q1 2026, an estimated $3.77M.
  • Labcorp made up 0.02% of HighTower Advisors's portfolio in Q1 2026, its #604 holding.
  • HighTower Advisors first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.